|
1
|
Lee BB, Lee EJ, Jung EH, Chun HK, Chang
DK, Song SY, Park J and Kim DH: Aberrant methylation of APC, MGMT,
RASSF2A, and Wif-1 genes in plasma as a biomarker for early
detection of colorectal cancer. Clin Cancer Res. 15:6185–6191.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Robertson KD, Uzvolgyi E, Liang G,
Talmadge C, Sumegi J, Gonzales FA and Jones PA: The human DNA
methyltransferases (DNMTs) 1, 3a and 3b: coordinate mRNA expression
in normal tissues and overexpression in tumors. Nucleic Acids Res.
27:2291–2298. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Schmidt WM, Sedivy R, Forstner B, Steger
GG, Zochbauer-Muller S and Mader RM: Progressive up-regulation of
genes encoding DNA methyltransferases in the colorectal
adenoma-carcinoma sequence. Mol Carcinog. 46:766–772. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Samuel MS, Suzuki H, Buchert M, Putoczki
TL, Tebbutt NC, Lundgren-May T, Christou A, Inglese M, Toyota M and
Heath JK: Elevated Dnmt3a activity promotes polyposis in Apc(Min)
mice by relaxing extracellular restraints on Wnt signaling.
Gastroenterology. 137:902–913. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Fan H, Liu D, Qiu X, Qiao F, Wu Q, Su X,
Zhang F, Song Y, Zhao Z and Xie W: A functional polymorphism in the
DNA methyltransferase-3A promoter modifies the susceptibility in
gastric cancer but not in esophageal carcinoma. BMC Med. 8:122010.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Fan H, Liu DS, Zhang SH, Hu JB, Zhang F
and Zhao ZJ: DNMT3B 579 G>T promoter polymorphism and risk of
esophagus carcinoma in Chinese. World J Gastroenterol.
14:2230–2234. 2008.
|
|
7
|
Yi JM, Tsai HC, Glockner SC, Lin S, Ohm
JE, Easwaran H, James CD, Costello JF, Riggins G and Eberhart CG:
Abnormal DNA methylation of CD133 in colorectal and glioblastoma
tumors. Cancer Res. 68:8094–8103. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Jass JR: Serrated adenoma of the
colorectum and the DNA-methylator phenotype. Nat Clin Pract Oncol.
2:398–405. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kuwai T, Kitadai Y, Tanaka S, Kuroda T,
Ochiumi T, Matsumura S, Oue N, Yasui W, Kaneyasu M and Tanimoto K:
Single nucleotide polymorphism in the hypoxia-inducible factor-1α
gene in colorectal carcinoma. Oncol Rep. 12:1033–1037. 2004.
|
|
10
|
Mort R, Mo L, McEwan C and Melton DW: Lack
of involvement of nucleotide excision repair gene polymorphisms in
colorectal cancer. Br J Cancer. 89:333–337. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Shin Y, Kim IJ, Kang HC, Park JH, Park HW,
Jang SG, Lee MR, Jeong SY, Chang HJ and Ku JL: A functional
polymorphism (−347 G-->GA) in the E-cadherin gene is associated
with colorectal cancer. Carcinogenesis. 25:2173–2176. 2004.
|
|
12
|
Shan K, Xiao-Wei M, Na W, Xiu-Feng Z,
Deng-Gui W, Wei G, Zheng-Mao Z and Yan L: Association of three
single nucleotide polymorphisms of the E-cadherin gene with
endometriosis in a Chinese population. Reproduction. 134:373–378.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Schneider-Stock R, Diab-Assef M, Rohrbeck
A, Foltzer-Jourdainne C, Boltze C, Hartig R, Schonfeld P, Roessner
A and Gali-Muhtasib H: 5-Aza-cytidine is a potent inhibitor of DNA
methyltransferase 3a and induces apoptosis in HCT-116 colon cancer
cells via Gadd45- and p53-dependent mechanisms. J Pharmacol Exp
Ther. 312:525–536. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Nelson RL, Dollear T, Freels S and Persky
V: The relation of age, race, and gender to the subsite location of
colorectal carcinoma. Cancer. 80:193–197. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Troisi RJ, Freedman AN and Devesa SS:
Incidence of colorectal carcinoma in the U.S.: an update of trends
by gender, race, age, subsite, and stage, 1975–1994. Cancer.
85:1670–1676. 1999.PubMed/NCBI
|
|
16
|
Anderson WF, Umar A and Brawley OW:
Colorectal carcinoma in black and white race. Cancer Metastasis
Rev. 22:67–82. 2003. View Article : Google Scholar : PubMed/NCBI
|
